OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
The purpose of this project is to see if weekly carboplatin compared with phenoxodiol in combination with weekly carboplatin, is effective against late stage ovarian cancer and to see what, if any, side-effects of treatment may result.
Fallopian Tube Cancer|Peritoneal Neoplasms|Ovarian Cancer
DRUG: phenoxodiol|DRUG: carboplatin|DRUG: placebo
The primary efficacy end-point is progression-free survival (PFS). PFS is the time from randomization until disease progression or death, Progression Free Survival
The secondary efficacy end-point is overall survival (OS), Overall survival
The purpose of this project is to see if weekly carboplatin compared with phenoxodiol in combination with weekly carboplatin, is effective against late stage ovarian cancer and to see what, if any, side-effects of treatment may result.